1,755 results on '"Antineoplastic agents -- Research"'
Search Results
2. Researchers at Amsterdam University Medical Center Release New Data on Cell Line [Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma]
3. Findings from Martin-Luther-University Yields New Data on Science (More Than Just an Eagle Killer: the Freshwater Cyanobacterium aetokthonos Hydrillicola Produces Highly Toxic Dolastatin Derivatives)
4. Findings in Animal Reproduction and Biotechnology Reported from Jeonju [Anti-oxidative effects of broccoli (Brassica oleracea var. italica) sprout extract in RAW 264.7 cell and cisplatin-induced testicular damage]
5. Reports from Savitribai Phule Pune University Add New Data to Findings in Green Synthesis (Green Synthesis of Cevo4 Nanoparticles Using Azadirechta Indica Leaves Extract and Their Promising Applications As an Antioxidant and Anticancer Agent)
6. Study Data from Zhongnan Hospital of Wuhan University Update Understanding of Materials and Design (Enhanced magnetothermal effect of high porous bioglass for both bone repair and antitumor therapy)
7. Investigators from University of Central Punjab Have Reported New Data on Green Synthesis (Green Synthesis of Gelatin-lipid Nanocarriers Incorporating Berberis Aristata Extract for Cancer Therapy; Physical Characterization, Pharmacological and ...)
8. Studies Conducted at University of Electronic Science and Technology of China on Synthetic Biology Recently Published (Breaking the Bottleneck in Anticancer Drug Development: Efficient Utilization of Synthetic Biology)
9. Data on Melanoma Discussed by Researchers at Shanghai Jiao Tong University (Two-dimensional Borocarbonitride Nanosheet-engineered Hydrogel As an All-in-one Platform for Melanoma Therapy and Skin Regeneration)
10. Barretos Cancer Hospital Researchers Publish New Studies and Findings in the Area of Molecular Science (Efficacy of Combined Use of Everolimus and Second-Generation Pan-EGRF Inhibitors in * * KRAS* * Mutant Non-Small Cell Lung Cancer Cell Lines)
11. New Study Findings from Department of Biology Illuminate Research in Biomedicine (Plants in Anticancer Drug Discovery: From Molecular Mechanism to Chemoprevention)
12. Findings in Artificial Organs Reported from Cardiothoracic and Vascular Department [Organ Care System Heart (Tm) In Donors Requiring High-risk Excision of Suspected Neoplastic Lesions]
13. University of Tours Researchers Provide Details of New Studies and Findings in the Area of Computational and Structural Biotechnology (Computational biotechnology guides elucidation of the biosynthesis of the plant anticancer drug camptothecin)
14. Reports on Biotechnology Findings from National Center for Radiation Research and Technology Provide New Insights (Production, bioprocess optimization and g-irradiation of Penicillium polonicum, as a new Taxol producing endophyte from Ginko ...)
15. New Metabolic Engineering Study Findings Have Been Reported by Researchers at Chinese Academy of Sciences (Recent Advances in Metabolic Engineering, Protein Engineering, and Transcriptome-Guided Insights Toward Synthetic Production of Taxol)
16. Sichuan University Researchers Have Provided New Data on Gliomas [Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma]
17. Findings from Edge University Broaden Understanding of Biosensors (Levan Modified Dna Biosensor for Voltammetric Detection of Daunorubicin-dna Interaction)
18. Findings from University of Illinois Reveals New Findings on miRNA-Based Therapy (Oligonucleotides and Micrornas Targeting Telomerase Subunits In Cancer Therapy)
19. Research Data from Jinan University Update Understanding of Biosensors (Anti-fouling poly adenine coating combined with highly specific CD20 epitope mimetic peptide for rituximab detection in clinical patients' plasma)
20. Studies in the Area of Xenografts Reported from University of Sydney (Pancreatic adenocarcinoma preferentially takes up and is suppressed by synthetic nanoparticles carrying apolipoprotein A-II and a lipid gemcitabine prodrug in mice)
21. Recent Research from Bahauddin Zakariya University Highlight Findings in Cancer Gene Therapy (Malignant Melanoma: Skin Cancer-diagnosis, Prevention, and Treatment)
22. Studies from Department of Food Science and Technology Have Provided New Information about Biomedicine [UHPLC/GC-TOF-MS metabolomics, MTT assay, and molecular docking studies reveal physostigmine as a new anticancer agent from the ethyl acetate ...]
23. Reports Outline Biomedical Chromatography Study Findings from Department of Food Science and Technology [UHPLC/GC-qTOF-MS metabolomics, MTT assay, and molecular docking studies reveal physostigmine as a new anticancer agent from the ethyl ...]
24. Study Findings from Delhi Technological University Provide New Insights into Protein and Peptide Research (Venom-Derived Bioactive Compounds as Potential Anticancer Agents: A Review)
25. Recent Findings from Nankai University Has Provided New Data on Cancer Gene Therapy (The enhanced efficacy of herpes simplex virus by lentivirus mediated VP22 and cytosine deaminase gene therapy against glioma)
26. New Biomedicine Study Findings Have Been Reported by Researchers at University of Groningen (Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine)
27. Study Data from Genentech Inc. Update Understanding of Cancer Therapy (Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP)
28. Researchers at University of Niigata Report Findings in Transplant Medicine (Bortezomib Eliminates Plasma Cells From a Renal Graft in Plasma Cell-Rich Acute Rejection)
29. Findings on Bioelectronics Detailed by Researchers at Huazhong University of Science and Technology (Dual-mode visible light-induced aptasensing platforms for bleomycin detection based on CdS-In2S3 heterojunction)
30. Findings from University of Niigata Broadens Understanding of Transplant Medicine (Bortezomib Eliminates Plasma Cells From a Renal Graft in Plasma Cell-Rich Acute Rejection)
31. Researchers at University of Niigata Detail Findings in Transplant Medicine (Bortezomib Eliminates Plasma Cells From a Renal Graft in Plasma Cell-Rich Acute Rejection)
32. Research Data from University of Swabi Update Understanding of Biomedicine (Luteolin, a flavonoid, as an anticancer agent: A review)
33. New Gastric Cancer Study Findings Recently Were Reported by Researchers at Zhengzhou University (Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a)
34. New Findings Reported from University of Colorado Describe Advances in Glycopeptides (R213G polymorphism in SOD3 protects against bleomycin-induced inflammation and attenuates induction of proinflammatory pathways)
35. New Findings Reported from Ege University Faculty of Medicine Describe Advances in Antineoplastic Monoclonal Antibodies (Role of consolidative radiation therapy for patients with mediastinal diffuse large B-cell lymphoma in the rituximab era)
36. Findings on B-Cell Lymphoma from P.G. Werthmann and Colleagues Provide New Insights (Complete Remission and Long-term Survival of a Patient with a Diffuse Large B-cell Lymphoma Under Viscum album Extracts After Resistance to R-CHOP: A Case ...)
37. Findings from Okayama University Reveals New Findings on Oral Cancer (Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab)
38. Data on Genetics Reported by Researchers at Harbin Medical University (The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation)
39. Findings from Affiliated Hospital of Nanjing University School of Medicine Provides New Data on Antineoplastic Monoclonal Antibodies (Bulky primary tibia mantle cell lymphoma achieved complete remission with CHOP and DHAP plus rituximab: A case ...)
40. Reports from University Hospital Advance Knowledge in Antineoplastic Monoclonal Antibodies (A new pharmacokinetic model for Y-90-ibritumomab tiuxetan based on 3-dimensional dosimetry)
41. New Antineoplastic Monoclonal Antibodies Findings from Catholic University of Leuven Discussed (Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy)
42. Findings from Chinese Academy of Sciences in Antineoplastic Monoclonal Antibodies Reported [STAT3 activation confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive breast cancer]
43. Studies from University of Jinan Add New Findings in the Area of Antineoplastic Monoclonal Antibodies (Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation)
44. Research Conducted at Beth Israel Deaconess Medical Center Has Provided New Information about JC Virus (Anti-JC virus antibody index changes in rituximab-treated multiple sclerosis patients)
45. Research Data from University of Colorado Update Understanding of Antineoplastic Monoclonal Antibodies (Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers)
46. Research Conducted at University Medical Center Has Provided New Information about Gastric Cancer [Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized ...]
47. New Findings in Gastric Cancer Described from Tehran University of Medical Sciences [MSLN (Mesothelin), ANTXR1 (TEM8), and MUC3A are the potent antigenic targets for CAR T cell therapy of gastric adenocarcinoma]
48. Findings on Anticancer Agents Reported by Researchers at ACECR (Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents)
49. Researchers from Catholic University of Leuven Discuss Findings in Breast Cancer [A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer]
50. Researchers at First Affiliated Hospital of Xi'an Jiaotong University Detail Findings in Gastric Cancer (Clinical use of trastuzumab combined with different chemotherapy regimens in multi-line treatment of advanced human epidermal growth factor ...)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.